Plasma catestatin level predicts sPESI score and mortality in acute pulmonary embolism

INTRODUCTION: Acute pulmonary embolism (APE) is an emergent cardiothoracic disorder. The PESI score is used to estimate 30-day mortality in patients diagnosed with non-high-risk APE. Also, there are biomarkers for predicting prognosis and mortality in APE. Catestatin (CST) is accepted as a marker of...

Descripción completa

Detalles Bibliográficos
Autores principales: Izci, Servet, Acar, Emrah, Inanir, Mehmet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2020
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277442/
https://www.ncbi.nlm.nih.gov/pubmed/32529106
http://dx.doi.org/10.5114/amsad.2020.95562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277442/
https://www.ncbi.nlm.nih.gov/pubmed/32529106
http://dx.doi.org/10.5114/amsad.2020.95562

Ejemplares similares